Correlation Between Somatic Mutation Burden, Neoantigen Load and Progression Free Survival in Multiple Myeloma: Analysis of MMRF CoMMpass Study

Miller Amber; Cattaneo Laura; Asmann Yan W.; Braggio Esteban; Keats Jonathan J.; Auclair Daniel; Lonial Sagar; Russell Stephen J.; Stewart A. Keith

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Correlation Between Somatic Mutation Burden, Neoantigen Load and Progression Free Survival in Multiple Myeloma: Analysis of MMRF CoMMpass Study

【24h】

Correlation Between Somatic Mutation Burden, Neoantigen Load and Progression Free Survival in Multiple Myeloma: Analysis of MMRF CoMMpass Study

机译：多发性骨髓瘤的体细胞突变负担，新抗原负荷与无进展生存之间的相关性：MMRF CoMMpass研究的分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共5页
作者
Miller Amber; Cattaneo Laura; Asmann Yan W.; Braggio Esteban; Keats Jonathan J.; Auclair Daniel; Lonial Sagar; Russell Stephen J.; Stewart A. Keith;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Correlation Between Somatic Mutation Burden, Neoantigen Load and Progression Free Survival in Multiple Myeloma: Analysis of MMRF CoMMpass Study [J] . Miller Amber, Cattaneo Laura, Asmann Yan W., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：多发性骨髓瘤的体细胞突变负担，新抗原负荷与无进展生存之间的相关性：MMRF CoMMpass研究的分析
2. Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis [J] . Avet-Loiseau Herve, Ludwig Heinz, Landgren Ola, Clinical lymphoma, myeloma & leukemia . 2020,第1期

机译：最小的残余疾病状态作为新诊断的多发性骨髓瘤研究的无进展生存率的替代终点：META分析
3. Progression-Free Survival Subset Analysis - Denosumab Vs Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Double-Dummy, Randomized Controlled Phase 3 Study [J] . Terpos Evangelos, Willenbacher Wolfgang, Shimizu Kazuyuki, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：无进展的生存次集分析 - Denosumab与骨病治疗新诊断的多发性骨髓瘤中的Zoledronic酸：国际，双盲，双假，随机对照第3研究
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Engineering the sporadic activation of oncogenes in vivo, by somatic hypermutation: Mouse models for lymphomas and multiple myeloma. [D] . Robbiani, Davide Filippo. 2005

机译：通过体细胞超突变工程化体内癌基因的偶然激活：淋巴瘤和多发性骨髓瘤的小鼠模型。
6. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma [O] . A Miller, Y Asmann, L Cattaneo, 2017

机译：高体细胞突变和新抗原负担与多发性骨髓瘤的无进展生存期降低相关
7. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma [O] . A Miller, Y Asmann, L Cattaneo, 2017

机译：高躯体突变和新洲突变负担与多发性骨髓瘤的无进展生存率下降相关

Correlation Between Somatic Mutation Burden, Neoantigen Load and Progression Free Survival in Multiple Myeloma: Analysis of MMRF CoMMpass Study

著录项

引文网络

相似文献

相关主题

期刊订阅